LIF and neoplasm: Interestingly, mice treated with anti-LIF showed an increase in CD8+ T cell tumor infiltration and most of the infiltrating CD8+ T cells expressed the CXCL9 receptor, CXCR3 (Fig. 4e, Supplementary Fig. 10a, b).